Jaids-Journal of Acquired Immune Deficiency Syndromes
Impact Factor Trend (2018–2026)
Clarivate IF trend for Jaids-Journal of Acquired Immune Deficiency Syndromes
SCImago Journal Rank citation prestige weighting
180 papers with at least that number of citations each
Aims & Scope
JAIDS: Journal of Acquired Immune Deficiency Syndromes seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
IMMUNOLOGY
INFECTIOUS DISEASES
IMMUNOLOGY
INFECTIOUS DISEASES
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisJaids-Journal of Acquired Immune Deficiency Syndromes (acronym: jaids, abbr: JAIDS-J ACQ IMM DEF, ISSN: 1525-4135) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1999. The periodical holds a Journal Impact Factor (JIF) of 2.30, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.066 (Q1), an H-index of 180.
The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 269 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,451 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics